180 related articles for article (PubMed ID: 31631254)
1. Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.
Kim DD; Guzauskas GF; Bennette CS; Basu A; Veenstra DL; Ramsey SD; Carlson JJ
Pharmacoeconomics; 2020 Feb; 38(2):171-179. PubMed ID: 31631254
[TBL] [Abstract][Full Text] [Related]
2. The value of value of information: best informing research design and prioritization using current methods.
Eckermann S; Karnon J; Willan AR
Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473
[TBL] [Abstract][Full Text] [Related]
3. Value of Information Choices that Influence Estimates: A Systematic Review of Prevailing Considerations.
Koffijberg H; Rothery C; Chalkidou K; Grutters J
Med Decis Making; 2018 Oct; 38(7):888-900. PubMed ID: 30188244
[TBL] [Abstract][Full Text] [Related]
4. Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation.
Grimm SE; Pouwels X; Ramaekers BLT; van Ravesteyn NT; Sankatsing VDV; Grutters J; Joore MA
Value Health; 2021 Aug; 24(8):1126-1136. PubMed ID: 34372978
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.
Bennette CS; Veenstra DL; Basu A; Baker LH; Ramsey SD; Carlson JJ
Med Decis Making; 2016 Jul; 36(5):641-51. PubMed ID: 27012232
[TBL] [Abstract][Full Text] [Related]
6. Use of value of information in UK health technology assessments.
Mohiuddin S; Fenwick E; Payne K
Int J Technol Assess Health Care; 2014 Dec; 30(6):553-70. PubMed ID: 25816821
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis.
Koffijberg H; Knies S; Janssen MP
Value Health; 2018 Feb; 21(2):203-209. PubMed ID: 29477402
[TBL] [Abstract][Full Text] [Related]
8. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
Rothery C; Strong M; Koffijberg HE; Basu A; Ghabri S; Knies S; Murray JF; Sanders Schmidler GD; Steuten L; Fenwick E
Value Health; 2020 Mar; 23(3):277-286. PubMed ID: 32197720
[TBL] [Abstract][Full Text] [Related]
9. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
11. An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial.
Vervaart M; Strong M; Claxton KP; Welton NJ; Wisløff T; Aas E
Med Decis Making; 2022 Jul; 42(5):612-625. PubMed ID: 34967237
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
13. Value of research and value of development in early assessments of new medical technologies.
Retèl VP; Grutters JP; van Harten WH; Joore MA
Value Health; 2013; 16(5):720-8. PubMed ID: 23947964
[TBL] [Abstract][Full Text] [Related]
14. Value of information analyses of economic randomized controlled trials: the treatment of intermittent claudication.
Groot Koerkamp B; Spronk S; Stijnen T; Hunink MG
Value Health; 2010; 13(2):242-50. PubMed ID: 19818058
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
16. Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the Electronic Health Records for Clinical Research (EHR4CR) European Project.
Beresniak A; Schmidt A; Proeve J; Bolanos E; Patel N; Ammour N; Sundgren M; Ericson M; Karakoyun T; Coorevits P; Kalra D; De Moor G; Dupont D
Contemp Clin Trials; 2016 Jan; 46():85-91. PubMed ID: 26600286
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
